Table I.

Patient Characteristics

	Non-Fanconi Anemia (n=9)	Fanconi Anemia (n=9)
Gender (M/F)	5/4	6/3
Age median (range)	52 (25–56)	7 (1–9)
Disease
Aplastic anemia	1	-
Acute myelogenous leukemia	5	-
Chronic myelogenous leukemia	1	-
Multiple myeloma	1	-
NonHodgkin lymphoma	1	-
Race/ethnicity
Caucasian	9	8
African American	0	1
FA Complementation Group
A	-	5
D1/D2	-	1
Other	-	1
Not determined	-	2
Days to engraftment median (range)	6.5 (6–25)	11 (10–12)
Day 100 TRM (95% CI)	20% (0–45%)	0%
Day 180 TRM (95% CI)	58% (26–905)	0%

TRM, treatment related mortality; engraftment is defined as ANC >500 cells µL for three consecutive days